• Home
  • Research areas
    • ADME-Tox
    • Biomarkers
    • Cell Biology and Signalling
    • Cell Sourcing – Cell Culture Technologies
    • Drug Discovery
    • Gene Expression – Molecular Biology
    • Stem Cells
    • Supplying Discovery Tools
  • Contact us
  • Meet the authors
  • Facebook
  • Google+
  • LinkedIn
  • Twitter
  • YouTube
Home
Research areas
    ADME-Tox
    Biomarkers
    Cell Biology and Signalling
    Cell Sourcing - Cell Culture Technologies
    Drug Discovery
    Gene Expression - Molecular Biology
    Stem Cells
    Supplying Discovery Tools
Contact us
Meet the authors
tebu-bio's blog - Acting and reacting in life sciences and biotechnologies
  • Home
  • Research areas
    • ADME-Tox
    • Biomarkers
    • Cell Biology and Signalling
    • Cell Sourcing – Cell Culture Technologies
    • Drug Discovery
    • Gene Expression – Molecular Biology
    • Stem Cells
    • Supplying Discovery Tools
  • Contact us
  • Meet the authors
Cell Sourcing - Cell Culture Technologies

Pluripotent stem cells for improved reprogrammed Human Sebocytes

07/09/2017 by Frédéric Samazan No Comments
Phenocell Sebocytes display the typical epithelial morphology of primary sebocytes with heterogeneity in cell size due to lipid accumulation.

Following the start of our recent collaboration with Phenocell, we’re pleased to be able to provide high quality Sebocytes developed from Human induced pluripotent stem cells (iPSC). Thanks to a perfectly standardized reprogramming protocol, they display lower batch to batch variability, allowing better reproducibility and accuracy of your experimental results.

Continue reading
ADME-Tox, Cell Sourcing - Cell Culture Technologies, Drug Discovery

Plateable Hepatocytes… the "one cell type doesn't fit all" syndrome

27/06/2014 by Jean-François Têtu, PhD No Comments

Hepatocytes are commonly used in drug discovery and preclinical drug development to perform experiments requiring intact cellular systems. Intact hepatocytes contain the major hepatic drug-metabolizing enzymes required to study the four categories of xenobiotic biotransformation: Hydrolysis, Reduction, Oxidation and Conjugation. Because of these enzymes, hepatocytes provide a viable and cost-effective alternative to in vivo compound testings.

Continue reading
tebu-bio

LAB SERVICES OUTSOURCING

• Protein production

• Plasmid Preps

• 3D Cell Culture
LEARN MORE

Most popular posts

  • HeLa cells: Origin of this important cell line in life science research
  • From RUO to IVD - the acronym guide to reagents' intended use
  • How to choose the perfect buffer to get a pure, stabilised, functional protein
  • Lipid-Ligand interaction tools: lipids are not scary intermediates anymore
  • Differentiate between Apoptosis, Necroptosis, Autophagy & Ferroptosis
My Tweets

Top contributors

Dimitri Szymczak, PhD
Dimitri Szymczak, PhD
  • New ATM and ATR inhibitor biomarker – How to study key sensors of DNA damage
  • Get closer to the real Host Cell Protein (HCP) quantity
Frédéric Samazan
Frédéric Samazan
  • Lympholyte®: The ideal tool for simple and viable lymphocytes isolation
  • CAR T-Cell therapy: new hope for Immunotherapy and Cancer treatment
Isabelle Nobiron
Isabelle Nobiron
  • Proteomics Biostats: get the most out of your array data
  • Hepatic Hyaluronan Content increased by Alcohol Consumption in Patients with Liver Steatosis
Isabelle Topin, PhD
Isabelle Topin, PhD
  • Monoclonal antibodies – all you need to know about antibody generation
  • Tips and Tricks: how to increase unstable protein expression in E. Coli
Philippe Fixe, PhD
Philippe Fixe, PhD
  • 10 Human Immune Checkpoint biomarkers quantified simultaneously
  • 3D cell culture: discover the new VitroGel™ 3D Hydrogel system

Copyright © 2018 - tebu-bio - visit our main website at tebu-bio.com